Weijing Cai
Weijing Cai publishes mostly in Clinical Biochemistry, Pulmonary and Respiratory Medicine and Oncology, on topics such as Advanced Glycation End Products research, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.
- World rank
- #70,671 of 7,710,434 ranked researchers
- Rank in United States
- #27,297 of 1,627,098
- Works
- 139
- Citations
- 12k
- Citations per work
- 84.9
What does Weijing Cai research?
Weijing Cai's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Medicine (27%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6143.7%
- Life Sciences4129.3%
- Health Sciences3827.0%
- Medicine3827.0%
- 1Clinical Biochemistry15% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Oncology9% of their works
- 4Molecular Biology8% of their works
- 5Cancer Research6% of their works
- 6Nephrology6% of their works
Research topics
Which keywords describe Weijing Cai's research?
The keywords of their largest research topics: Oxidative Stress, Diabetes, Advanced Glycation End Products, HMGB1, Targeted Therapy, Clinical Trials, ALK Inhibitors and EGFR Mutations.
- ß-Alanine Supplementation
- Carnosine
- Glomerular Filtration Rate
- Mutational Signatures
- Cancer Genomics
- Small-Cell Lung Cancer
- Diabetic Nephropathy
- EGFR Mutations
- Clinical Trials
- HMGB1
- Diabetes
- Oxidative Stress
- Advanced Glycation End Products
- Targeted Therapy
- ALK Inhibitors
- Chemotherapy
- Genomic Profiles
- Antioxidants
- Insulin Resistance
- Chronic Kidney Disease
- CT Screening
- Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Oxidative Stress793 topics
- Diabetes702 topics
- Advanced Glycation End Products591 topic
- HMGB1591 topic
- Targeted Therapy503 topics
- Clinical Trials392 topics
- ALK Inhibitors271 topic
- EGFR Mutations271 topic
- Chemotherapy212 topics
- Diabetic Nephropathy192 topics
- Genomic Profiles121 topic
- Small-Cell Lung Cancer121 topic
- Antioxidants111 topic
- Cancer Genomics111 topic
- Insulin Resistance111 topic
- Mutational Signatures111 topic
- Chronic Kidney Disease101 topic
- Glomerular Filtration Rate101 topic
- CT Screening91 topic
- Carnosine91 topic
- Lung Cancer91 topic
- ß-Alanine Supplementation91 topic
Where does Weijing Cai work?
Weijing Cai's main affiliation in the publication record is Icahn School of Medicine at Mount Sinai, United States.
How many publications and citations does Weijing Cai have?
OpenAlex counts 139 works and 11,802 citations for Weijing Cai, an h-index of 57, ranking #70,671 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Weijing Cai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.